Parexel News (NASDAQ:PRXL)
| Latest Parexel News Headlines | | Date | Time | Source | | | 07/22/2008 | 7:15AM | PRNUS | ClinPhone Shareholders Approve Acquisition by PAREXEL
BOSTON, July 22 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services organization ("PAREXEL" or the "Company"), today provided an update with regard to the previously announced proposal whereby an indirect wholly owned subsidiary of PAREXEL will acquire... More...>> |
| 07/16/2008 | 9:00AM | PRNUS | PAREXEL Promotes Dr. Mark A. Goldberg to Chief Operating Officer
BOSTON, July 16 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services organization, announced today that it has promoted Mark A. Goldberg, M.D., to Chief Operating Officer (COO). Dr. Goldberg previously served as President of Clinical Research Services... More...>> |
| 07/08/2008 | 6:00AM | PRNUS | PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2008 Earnings Release and Conference Call
BOSTON, July 8 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL) will release Fourth Quarter and Fiscal Year 2008 financial results on Wednesday, August 6, 2008 after the close of the stock market. The announcement will be available on PAREXEL's website at http://www.parexel.com/ and on the... More...>> |
| 06/24/2008 | 4:02PM | PRNUS | PAREXEL International Updates Earnings Guidance in Conjunction with Its Investor Day
BOSTON, June 24 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL) announced today that it will discuss forward-looking earnings expectations for the fourth quarter of Fiscal Year 2008 (ending June 30, 2008), for Fiscal Year 2008 in its entirety, and for Fiscal Year 2009 at its Investor Day being... More...>> |
| 06/23/2008 | 6:00AM | PRNUS | PAREXEL Data Reveal A Record High Number of Clinical Trials Initiated
BOSTON, June 23 /PRNewswire-FirstCall/ -- According to new data from PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services organization, the number of new industry-sponsored clinical trial initiations, or starts, surged another 12 percent to a record high in 2007. PAREXEL's analysis... More...>> |
| 06/19/2008 | 12:38PM | PRNUS | PAREXEL Expands Global Clinical Logistics Capabilities
Companies can avoid developing their own internal systems and managing multiple vendors by taking advantage of PAREXEL's global team of experts and distribution infrastructure
BOSTON, June 19 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services organization... More...>> |
| 06/18/2008 | 9:15AM | PRNUS | Parexel Invites Public to Listen to Live Webcast of Its Investor Day June 25, 2008
BOSTON, June 18 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services provider, today announced that it will provide a live webcast of its Investor Day on Wednesday, June 25, 2008, from 8:30 a.m. to 12:30 p.m. (EDT).
All interested parties are invited... More...>> |
| 06/17/2008 | 6:00AM | PRNUS | PAREXEL Enhances Early Phase Clinical Development Offering for Central Nervous System Studies
BOSTON, June 17 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services provider, today announced that it is expanding its clinical pharmacology capabilities in the Central Nervous System (CNS) therapeutic area. PAREXEL is enhancing existing services in... More...>> |
| 06/16/2008 | 6:00AM | PRNUS | PAREXEL Experts to Address Key Industry Topics at the Drug Information Association 44th Annual Meeting
BOSTON, June 16 /PRNewswire-FirstCall/ -- Experts from PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services organization, will present in more than 20 sessions at the Drug Information Association (DIA) 44th Annual Meeting. The meeting will be held June 22 -- 26, 2008 at the Boston... More...>> |
| 06/13/2008 | 6:53AM | PRNUS | PAREXEL Reaches Agreement To Acquire ClinPhone
Combined Capabilities to Create One of the Industry's Largest eClinical Technology Offerings
BOSTON, June 13 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services organization, today announced that the Boards of PAREXEL International and ClinPhone plc... More...>> |
| 06/05/2008 | 10:18AM | PRNUS | PAREXEL International to Present at Goldman Sachs 29th Annual Global Healthcare Conference
BOSTON, June 5 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL) announced today it will be presenting at the Goldman Sachs 29th Annual Global Healthcare Conference at The Ritz Carlton - Laguna Niguel in Dana Point, California. James Winschel, Senior Vice President and Chief Financial Officer... More...>> |
| 06/04/2008 | 6:00AM | PRNUS | PAREXEL Product Development and Regulatory Experts to Attend the 2008 BIO International Convention
BOSTON, Mass., June 4 /PRNewswire-FirstCall/ -- Experts with in-depth product development and regulatory strategy experience from PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services organization, will attend the 2008 BIO International Convention to be held June 17-20, 2008 at... More...>> |
| 06/02/2008 | 6:00AM | PRNUS | Perceptive Informatics Enhances Medical Imaging Capabilities for Assessment of Cardiac Function
BOSTON, June 2 /PRNewswire-FirstCall/ -- Perceptive Informatics, the technology subsidiary of PAREXEL International Corporation (NASDAQ:PRXL), today announced that it has integrated its leading medical imaging technology with the functionality of DigiView, a specialized image management and reporting system provided... More...>> |
| 05/12/2008 | 4:05PM | PRNUS | PAREXEL International to Present at Robert W. Baird's 2008 Growth Stock Conference
BOSTON, May 12 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL) announced today it will be presenting at the Robert W. Baird 2008 Growth Stock Conference in Chicago, Illinois. James Winschel, Senior Vice President and Chief Financial Officer will be making a formal presentation on PAREXEL at... More...>> |
| 04/30/2008 | 6:00AM | PRNUS | PAREXEL Appoints Leading Biostatistician Dr. Imogene Grimes to Vice President of Data Sciences Strategic Services
BOSTON, April 30 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services organization, has appointed Imogene Grimes, Ph.D., to Vice President of Data Sciences Strategic Services. Dr. Grimes, a leading biostatistician with more than 25 years of experience... More...>> |
| 04/23/2008 | 4:21PM | PRNUS | PAREXEL Reports Third Quarter Fiscal Year 2008 Financial Results
- Consolidated service revenue of $245.3 million grows 28% year-over-year
BOSTON, April 23 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL) today announced its financial results for the third quarter and nine months ended March 31, 2008. The past and current period results reflect a two-for-one... More...>> |
| 04/14/2008 | 6:00AM | PRNUS | Perceptive Informatics Improves Clinical Site Monitoring Access and Flexibility With Portable USB Drive Capability
BOSTON, April 14 /PRNewswire-FirstCall/ -- Perceptive Informatics, the technology subsidiary of PAREXEL International Corporation (NASDAQ:PRXL), today announced the availability of its clinical site management and monitoring software, IMPACT(R) MySites, on a portable USB drive. Clinical monitors can now securely upload... More...>> |
| 04/10/2008 | 11:50AM | PRNUS | PAREXEL Experts to Offer Insights Into Outsourcing Best Practices at 17th Annual Partnerships with CROs Conference
BOSTON, April 10 /PRNewswire-FirstCall/ -- Senior experts from PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services provider, will discuss best practices for successful partnerships at the 17th Annual Partnerships with CROs conference, to be held April 14-16, 2008 in Las Vegas... More...>> |
| 04/02/2008 | 12:21PM | PRNUS | PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business
BOSTON, April 2, 2008 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services organization, today announced that Larry Ereshefsky, Pharm.D., F.C.C.P., B.C.C.P., and Malek Bajbouj, M.D., have been appointed as Vice Presidents of Clinical Pharmacology Consulting... More...>> |
| 03/31/2008 | 12:16PM | PRNUS | PAREXEL Expands Global Clinical Pharmacology Capabilities
BOSTON, March 31 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services provider, today announced that the Company had completed the expansion of three Clinical Pharmacology Research Units located in Baltimore, Maryland in the United States; London, United... More...>> |
|
|
|